Literature DB >> 26382034

Congenital atresia of the left main coronary artery in an adult: A rare anomaly with an unfavorable prognosis. Review of the literature.

Leire Unzué1, Eulogio García2, Francisco Javier Parra3, Jesús Palomo4, Leticia Fernández Friera2, Jorge Solís2.   

Abstract

Congenital atresia of the left main coronary artery (LMCA) is one of the rarest congenital anomalies, which may have an unfavorable prognosis leading to myocardial ischemia, ventricle dysfunction or even sudden cardiac death. There are 34 cases of LMCA in adults reported in the literature, most of them successfully treated with coronary revascularization. We report the case of an adult with LMCA who presented with terminal heart failure that required biventricular assistance and heart transplant. Published by Elsevier Inc.

Entities:  

Keywords:  Coronary artery anomaly; Left main coronary artery atresia

Mesh:

Year:  2015        PMID: 26382034     DOI: 10.1016/j.carrev.2015.08.006

Source DB:  PubMed          Journal:  Cardiovasc Revasc Med        ISSN: 1878-0938


  4 in total

1.  Congenital left main coronary artery atresia presenting as syncope and generalized seizure during exercise in a 13-year-old boy.

Authors:  Shuhei Fujita; Akira Sato; Yoshiki Nagata; Kazuo Usuda; Akira Murata; Kiyoshi Hatasaki
Journal:  J Cardiol Cases       Date:  2017-07-19

2.  Unusual congenital coronary artery anomaly in a young adult presenting as sudden cardiac arrest.

Authors:  Manuel Cortes; Carlos A Roldan; Stacey Clegg
Journal:  BMJ Case Rep       Date:  2018-04-24

3.  Clinical Characteristics of Congenital Atresia of the Left Main Coronary Artery in 12 Children.

Authors:  Xiaokun Jiang; Wenqian Ye; Yanyan Xiao; Ling Han; Wenhong Ding; Wenxiu Li; Mei Jin; Xiaofang Wang; Qi Meng
Journal:  Front Pediatr       Date:  2022-04-29       Impact factor: 3.418

4.  Congenital Giant Right Coronary Artery to Pulmonary Artery Fistula and Congenital Left Main Coronary Artery Atresia: A Case Report.

Authors:  Ya-Hui Ding; Hai Zou
Journal:  Medicine (Baltimore)       Date:  2016-02       Impact factor: 1.889

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.